Plenaxis (abarelix), a new drug for advanced prostate cancer
Some men will be asking about Plenaxis (abarelix), a new drug for advanced prostate cancer.
Plenaxis suppresses testosterone by blocking gonadotropin-releasing hormone receptors. It doesn't cause an initial testosterone surge...like Lupron and other gonadotropin agonists.
But Plenaxis has a serious drawback...it causes life-threatening allergic reactions in almost 4% of patients.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote